• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    GE HealthCare Technologies Inc. to Join the Nasdaq-100 Index® Beginning June 7, 2023

    5/30/23 8:00:00 PM ET
    $FISV
    $GEHC
    $NDAQ
    Real Estate
    Real Estate
    Medical Electronics
    Health Care
    Get the next $FISV alert in real time by email

    NEW YORK, May 30, 2023 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced that GE HealthCare Technologies Inc. (NASDAQ:GEHC), will become a component of the Nasdaq-100 Index® (NASDAQ:NDX), the Nasdaq-100 Equal Weighted Index (NASDAQ:NDXE), and the Nasdaq-100 Ex-Tech Sector Index (NASDAQ:NDXX) prior to market open on Wednesday, June 7, 2023. GE HealthCare Technologies Inc. will replace Fiserv, Inc. (NASDAQ:FISV) in the Nasdaq-100 Index®, the Nasdaq-100 Equal Weighted Index, and the Nasdaq-100 Ex-Tech Sector Index. Fiserv, Inc. will also be removed from the Nasdaq-100 ESG Index (NASDAQ:NDXESG) prior to market open on Wednesday, June 7, 2023.

    For more information about the company, go to https://www.gehealthcare.com/.

    About Nasdaq

    Nasdaq (NASDAQ:NDAQ) is a global technology company serving the capital markets and other industries. Our diverse offering of data, analytics, software and services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions and career opportunities, visit us on LinkedIn, on Twitter @Nasdaq, or at www.nasdaq.com.

    The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular financial product or an overall investment strategy. Neither The NASDAQ OMX Group, Inc. nor any of its affiliates makes any recommendation to buy or sell any financial product or any representation about the financial condition of any company or fund. Statements regarding Nasdaq's proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

    - NDAQG -

    Media Contact: Camille Stafford, Nasdaq
    Issuer & Investor Contact:  Index Client Services, Nasdaq
      [email protected]

     



    Primary Logo

    Get the next $FISV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FISV
    $GEHC
    $NDAQ

    CompanyDatePrice TargetRatingAnalyst
    Fiserv Inc.
    $FISV
    2/2/2026Buy → Neutral
    Northcoast
    Fiserv Inc.
    $FISV
    1/27/2026$70.00Neutral
    Cantor Fitzgerald
    GE HealthCare Technologies Inc.
    $GEHC
    1/15/2026$77.00Neutral → Sell
    UBS
    Fiserv Inc.
    $FISV
    12/4/2025$85.00Overweight → Neutral
    Analyst
    Nasdaq Inc.
    $NDAQ
    11/20/2025$110.00Equal-Weight → Overweight
    Morgan Stanley
    GE HealthCare Technologies Inc.
    $GEHC
    10/13/2025$86.00Equal Weight
    Barclays
    GE HealthCare Technologies Inc.
    $GEHC
    10/7/2025$83.00Buy → Neutral
    Citigroup
    Nasdaq Inc.
    $NDAQ
    7/25/2025$115.00Neutral → Buy
    UBS
    More analyst ratings

    $FISV
    $GEHC
    $NDAQ
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    GE HealthCare achieves MRI portfolio milestone with FDA clearances for next-generation SIGNA MRI technology designed to enhance precision imaging and clinical efficiency

    SIGNA Sprint with Freelium, a new 1.5T sealed magnet MRI system, combines a sustainable design with uncompromised image quality, and operational autonomy to expand access to advanced MR, even in remote settings. SIGNA Bolt, a new 3T MRI scanner, is engineered to support precision diagnostics, clinical efficiency, and advanced research capability. Both new systems are powered by SIGNA One, an ecosystem of AI-driven workflow solutions designed to reduce inefficiencies and support MRI exams from plan to scan and beyond. GE HealthCare (NASDAQ:GEHC) announced today 510(k) clearance of three new magnetic resonance (MR) innovations with the U.S. Food and Drug Administration (FDA): SIGNA™

    2/19/26 9:00:00 AM ET
    $GEHC
    Medical Electronics
    Health Care

    GE HealthCare builds on BARDA collaboration with approximately $35 million expansion to advance artificial intelligence-powered ultrasound for trauma care and emergency preparedness

    GE HealthCare (NASDAQ:GEHC) today announced a new approximately $35 million expansion to a previous contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). The expansion is structured as a cost-share between BARDA and GE HealthCare, with BARDA providing the majority of funding. This jointly funded expanded agreement builds on the existing program announced in October 2023 and reflects continued momentum to develop artificial intelligence (AI)-powered ultrasound solutions and new platforms to support trauma assessment and preparedn

    2/17/26 9:00:00 AM ET
    $GEHC
    Medical Electronics
    Health Care

    GE HealthCare announces cash dividend for first quarter of 2026

    The Board of Directors of GE HealthCare Technologies Inc. (NASDAQ:GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the first quarter of 2026 payable on May 15, 2026, to all shareholders of record as of April 3, 2026. About GE HealthCare Technologies Inc. GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world's most complex diseases. Serving patients and providers for 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine across its Imaging, Advanced Visualization Solutions, Patie

    2/12/26 6:11:00 PM ET
    $GEHC
    Medical Electronics
    Health Care

    $FISV
    $GEHC
    $NDAQ
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Torgeby Johan bought $958,320 worth of shares (12,000 units at $79.86), increasing direct ownership by 42% to 40,797 units (SEC Form 4)

    4 - NASDAQ, INC. (0001120193) (Issuer)

    2/19/26 4:00:18 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    Large owner Investor Ab bought $15,835,040 worth of shares (200,000 units at $79.18) (SEC Form 4)

    4 - NASDAQ, INC. (0001120193) (Issuer)

    2/13/26 3:56:39 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    Chief Financial Officer Todd Paul M bought $1,060,970 worth of shares (17,000 units at $62.41), increasing direct ownership by 228% to 24,453 units (SEC Form 4)

    4 - FISERV INC (0000798354) (Issuer)

    12/2/25 5:58:53 PM ET
    $FISV
    Real Estate

    $FISV
    $GEHC
    $NDAQ
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Fiserv downgraded by Northcoast

    Northcoast downgraded Fiserv from Buy to Neutral

    2/2/26 7:53:56 AM ET
    $FISV
    Real Estate

    Cantor Fitzgerald initiated coverage on Fiserv with a new price target

    Cantor Fitzgerald initiated coverage of Fiserv with a rating of Neutral and set a new price target of $70.00

    1/27/26 8:46:26 AM ET
    $FISV
    Real Estate

    GE HealthCare downgraded by UBS with a new price target

    UBS downgraded GE HealthCare from Neutral to Sell and set a new price target of $77.00

    1/15/26 8:32:16 AM ET
    $GEHC
    Medical Electronics
    Health Care

    $FISV
    $GEHC
    $NDAQ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Best Kenneth was granted 15,871 shares, increasing direct ownership by 31% to 66,561 units (SEC Form 4)

    4 - FISERV INC (0000798354) (Issuer)

    2/20/26 7:37:15 AM ET
    $FISV
    Real Estate

    Chief Financial Officer Todd Paul M was granted 45,231 shares, increasing direct ownership by 185% to 69,684 units (SEC Form 4)

    4 - FISERV INC (0000798354) (Issuer)

    2/20/26 7:36:49 AM ET
    $FISV
    Real Estate

    Chief Admin. and Legal Officer Rosman Adam L. was granted 65,665 shares, increasing direct ownership by 102% to 130,231 units (SEC Form 4)

    4 - FISERV INC (0000798354) (Issuer)

    2/20/26 7:36:18 AM ET
    $FISV
    Real Estate

    $FISV
    $GEHC
    $NDAQ
    SEC Filings

    View All

    SEC Form 8-K filed by Fiserv Inc.

    8-K - FISERV INC (0000798354) (Filer)

    2/20/26 7:30:35 AM ET
    $FISV
    Real Estate

    SEC Form 10-K filed by Fiserv Inc.

    10-K - FISERV INC (0000798354) (Filer)

    2/19/26 4:18:00 PM ET
    $FISV
    Real Estate

    Amendment: SEC Form SCHEDULE 13G/A filed by GE HealthCare Technologies Inc.

    SCHEDULE 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)

    2/13/26 1:22:49 PM ET
    $GEHC
    Medical Electronics
    Health Care

    $FISV
    $GEHC
    $NDAQ
    Leadership Updates

    Live Leadership Updates

    View All

    Walmart Inc. to Join the Nasdaq-100 Index® Beginning January 20th, 2026

    NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced that Walmart Inc. (NASDAQ:WMT), will become a component of the Nasdaq-100 Index® (NDX®), the Nasdaq-100 Equal Weighted™ Index (NDXE™), and the Nasdaq-100 Ex-Tech Sector™ Index (NDXX™) prior to market open on Tuesday, January 20, 2026 - the first trading day following the third Friday of the month. Walmart Inc. will replace AstraZeneca PLC (NASDAQ:AZN) in the Nasdaq-100 Index®, the Nasdaq-100 Equal Weighted Index, and the Nasdaq-100 Ex-Tech Sector Index. AstraZeneca PLC will also be removed from the Nasdaq-100 ESG™ Index (NDXESG™), Nasdaq-100 ex Top 30™​ (NDX70™), Nasdaq-100 ex Top 30​ UCITS™ (NDX70U™), Nasdaq

    1/9/26 8:00:00 PM ET
    $AZN
    $NDAQ
    $WMT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Investment Bankers/Brokers/Service
    Finance

    Nasdaq Maintains Over a Decade of Listings Leadership in 2025

    Largest Exchange Transfer in History & Biggest IPO of the Year Highest Capital Raised Since 2021 - $46.65 Billion Raised NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) announced today that in 2025 it raised a total of $46.65 billion from new listings, marking the strongest year for capital raise since 2021. In addition, 22 companies transferred their corporate listings to Nasdaq in 2025 including Walmart, the largest exchange transfer in history. Since 2005, companies transferring their listing to Nasdaq have represented more than $4 trillion in total market value. "2025 marked a meaningful resurgence for the public markets. Companies at every stage continue to choose

    12/18/25 7:00:00 AM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    Fiserv Appoints Walter Pritchard as Senior Vice President, Head of Investor Relations

    Fiserv, Inc. (NASDAQ:FISV), a leading global provider of payments and financial technology, today announced the appointment of Walter Pritchard as Senior Vice President, Head of Investor Relations, effective December 1, 2025. Pritchard brings more than 25 years of experience in investor relations, corporate strategy, finance and equity research. Most recently, he served as Senior Vice President of Investor Relations and Corporate Development at Palo Alto Networks, where he helped align company strategy with external investor messaging and led corporate development and strategic finance to support the company's evolution and growth. Prior to Palo Alto Networks, Pritchard served as Managing

    12/1/25 8:00:00 AM ET
    $FISV
    Real Estate

    $FISV
    $GEHC
    $NDAQ
    Financials

    Live finance-specific insights

    View All

    GE HealthCare announces cash dividend for first quarter of 2026

    The Board of Directors of GE HealthCare Technologies Inc. (NASDAQ:GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the first quarter of 2026 payable on May 15, 2026, to all shareholders of record as of April 3, 2026. About GE HealthCare Technologies Inc. GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world's most complex diseases. Serving patients and providers for 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine across its Imaging, Advanced Visualization Solutions, Patie

    2/12/26 6:11:00 PM ET
    $GEHC
    Medical Electronics
    Health Care

    Fiserv Reports Fourth Quarter and Full Year 2025 Results

    GAAP revenue growth of 1% in the quarter and 4% for the full year;GAAP EPS decreased 8% in the quarter and increased 18% for the full year;Organic revenue was flat in the quarter and increased 4% for the full year;Adjusted EPS decreased 21% in the quarter and 2% for the full year;Company expects 2026 organic revenue growth of 1% to 3%and adjusted EPS of $8.00 to $8.30 MILWAUKEE, Wis., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Fiserv, Inc. (NASDAQ:FISV), a leading global provider of payments and financial services technology solutions, today reported financial results for the fourth quarter and full year 2025. Fourth Quarter and Full Year 2025 GAAP Results GAAP revenue for the company increased

    2/10/26 7:00:00 AM ET
    $FISV
    Real Estate

    GE HealthCare reports fourth quarter and full year 2025 financial results

    Company exceeds topline and earnings per share expectations; demonstrates operational resilience Fourth quarter 2025 highlights(1) Revenue growth of 7.1%, including Organic revenue growth* of 4.8%, driven primarily by the U.S. and Europe, the Middle East and Africa (EMEA) Net income margin of 10.3% and Adjusted earnings before interest and taxes (EBIT) margin* of 16.7% Diluted earnings per share (EPS) of $1.29 and Adjusted EPS* of $1.44 Cash flow from operating activities of $1.0 billion and Free cash flow* of $916 million Full year 2025 highlights(1) Revenue growth of 4.8%, including Organic revenue growth* of 3.5% Organic orders growth of 5.2% Net income margin o

    2/4/26 6:20:00 AM ET
    $GEHC
    Medical Electronics
    Health Care

    $FISV
    $GEHC
    $NDAQ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Nasdaq Inc.

    SC 13G/A - NASDAQ, INC. (0001120193) (Subject)

    11/12/24 3:53:01 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    Amendment: SEC Form SC 13G/A filed by GE HealthCare Technologies Inc.

    SC 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)

    11/12/24 12:53:28 PM ET
    $GEHC
    Medical Electronics
    Health Care

    SEC Form SC 13G filed by Nasdaq Inc.

    SC 13G - NASDAQ, INC. (0001120193) (Subject)

    11/8/24 10:52:39 AM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance